ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,226,831 | +60.8% | 113,788 | +31.1% | 0.66% | +58.2% |
| Q3 2022 | $1,385,000 | +132.4% | 86,785 | +232.6% | 0.42% | +210.4% |
| Q3 2020 | $596,000 | +61.1% | 26,090 | +47.6% | 0.13% | +48.9% |
| Q2 2020 | $370,000 | +26.3% | 17,680 | +48.6% | 0.09% | +233.3% |
| Q3 2018 | $293,000 | -0.3% | 11,897 | -20.6% | 0.03% | 0.0% |
| Q2 2018 | $294,000 | +4.6% | 14,982 | 0.0% | 0.03% | +3.8% |
| Q1 2018 | $281,000 | – | 14,982 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |